Olaplex (OLPX) Financials

$1.25 -0.02 (-1.57%)

Closing price 04:00 PM Eastern

Extended Trading

$1.25 +0.00 (+0.40%)

As of 04:31 PM Eastern

Annual Income Statements for Olaplex

This table shows Olaplex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	244	62	20
Consolidated Net Income / (Loss)	244	62	20
Net Income / (Loss) Continuing Operations	244	62	20
Total Pre-Tax Income	305	77	27
Total Operating Income	364	108	67
Total Gross Profit	520	319	292
Total Revenue	704	458	423
Operating Revenue	704	458	423
Total Cost of Revenue	185	140	130
Operating Cost of Revenue	185	140	130
Total Operating Expenses	155	210	225
Selling, General & Admin Expense	114	169	182
Amortization Expense	41	41	44
Total Other Income / (Expense), net	-59	-32	-40
Interest Expense	63	58	60
Interest & Investment Income	2.78	19	25
Other Income / (Expense), net	0.83	7.62	-5.82
Income Tax Expense	61	15	7.39
Basic Earnings per Share	$0.38	$0.09	$0.03
Weighted Average Basic Shares Outstanding	649.09M	654.59M	661.98M
Diluted Earnings per Share	$0.35	$0.09	$0.03
Weighted Average Diluted Shares Outstanding	691.01M	677.58M	665.40M
Weighted Average Basic & Diluted Shares Outstanding	651.90M	660.76M	664.62M

This table shows Olaplex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	61	34	21	6.16	20	14	7.75	5.78	15	-8.80
Consolidated Net Income / (Loss)	61	34	21	6.16	20	14	7.75	5.78	15	-8.80
Net Income / (Loss) Continuing Operations	61	34	21	6.16	20	14	7.75	5.78	15	-8.80
Total Pre-Tax Income	76	41	25	7.95	26	17	10	7.68	20	-11
Total Operating Income	89	47	36	19	37	17	20	16	28	3.05
Total Gross Profit	130	92	81	77	84	77	71	72	82	67
Total Revenue	176	131	114	109	124	112	99	104	119	101
Operating Revenue	176	131	114	109	124	112	99	104	119	101
Total Cost of Revenue	47	39	33	32	40	35	28	32	37	34
Operating Cost of Revenue	47	39	33	32	40	35	28	32	37	34
Total Operating Expenses	41	45	45	59	47	60	52	56	54	64
Selling, General & Admin Expense	31	35	35	48	36	49	40	45	43	53
Amortization Expense	10	10	10	10	10	10	11	11	11	11
Total Other Income / (Expense), net	-13	-5.85	-10	-11	-10	0.09	-9.25	-8.60	-8.34	-14
Interest Expense	10	13	14	15	15	15	15	15	16	15
Interest & Investment Income	-	-	3.38	4.47	5.18	5.80	6.20	6.26	6.61	6.31
Other Income / (Expense), net	-2.25	4.68	0.24	-0.60	-0.97	8.95	-0.95	-0.26	0.67	-5.28
Income Tax Expense	15	7.58	4.30	1.80	5.89	3.15	2.62	1.90	4.86	-2.00
Basic Earnings per Share	$0.09	$0.05	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)
Weighted Average Basic Shares Outstanding	649.10M	649.09M	651.73M	654.35M	654.70M	654.59M	660.82M	661.73M	662.25M	661.98M
Diluted Earnings per Share	$0.09	$0.04	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)
Weighted Average Diluted Shares Outstanding	691.26M	691.01M	683.49M	680.35M	678.76M	677.58M	663.57M	663.55M	666.15M	665.40M
Weighted Average Basic & Diluted Shares Outstanding	649.18M	651.90M	654.28M	654.70M	654.73M	660.76M	661.76M	661.98M	662.92M	664.62M

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Change in Cash & Equivalents	136	144	120
Net Cash From Operating Activities	255	178	143
Net Cash From Continuing Operating Activities	255	178	143
Net Income / (Loss) Continuing Operations	244	62	20
Consolidated Net Income / (Loss)	244	62	20
Depreciation Expense	0.36	0.48	0.49
Amortization Expense	50	52	55
Non-Cash Adjustments To Reconcile Net Income	35	25	22
Changes in Operating Assets and Liabilities, net	-74	38	46
Net Cash From Investing Activities	-2.68	-3.61	-4.89
Net Cash From Continuing Investing Activities	-2.68	-3.61	-4.89
Purchase of Property, Plant & Equipment	-0.65	-0.38	-1.12
Acquisitions	-2.03	-3.24	-3.77
Net Cash From Financing Activities	-116	-30	-19
Net Cash From Continuing Financing Activities	-116	-30	-19
Repayment of Debt	-792	-8.44	-6.75
Issuance of Debt	675	0.00	0.00
Other Financing Activities, net	1.10	-22	-12
Cash Interest Paid	41	60	60
Cash Income Taxes Paid	60	7.74	12

This table details how cash moves in and out of Olaplex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	51	73	47	9.08	51	37	41	0.42	31	47
Net Cash From Operating Activities	54	74	48	27	53	49	44	16	33	50
Net Cash From Continuing Operating Activities	54	74	48	27	53	49	44	16	33	50
Net Income / (Loss) Continuing Operations	61	34	21	6.16	20	14	7.75	5.78	15	-8.80
Consolidated Net Income / (Loss)	61	34	21	6.16	20	14	7.75	5.78	15	-8.80
Depreciation Expense	0.08	0.13	0.12	0.11	0.11	0.14	0.15	0.14	0.11	0.09
Amortization Expense	14	11	13	13	13	13	14	13	14	14
Non-Cash Adjustments To Reconcile Net Income	3.81	4.31	4.89	6.46	6.59	7.43	4.31	4.88	4.10	9.20
Changes in Operating Assets and Liabilities, net	-25	24	9.60	1.53	13	14	18	-8.04	0.65	36
Net Cash From Investing Activities	-0.77	-0.97	-0.63	-1.37	-0.91	-0.71	-1.08	-1.09	-1.19	-1.52
Net Cash From Continuing Investing Activities	-0.77	-0.97	-0.63	-1.37	-0.91	-0.71	-1.08	-1.09	-1.19	-1.52
Purchase of Property, Plant & Equipment	-0.03	-0.55	-0.11	-0.02	-0.11	-0.14	-0.45	-0.11	-0.13	-0.43
Acquisitions	-0.74	-0.42	-0.52	-1.34	-0.80	-0.58	-0.63	-0.99	-1.06	-1.09
Net Cash From Financing Activities	-1.62	0.86	-0.93	-17	-1.34	-12	-1.52	-15	-1.37	-1.00
Net Cash From Continuing Financing Activities	-1.62	0.86	-0.93	-17	-1.34	-12	-1.52	-15	-1.37	-1.00
Repayment of Debt	-1.69	0.00	-3.38	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69	-1.69
Other Financing Activities, net	0.07	0.86	2.45	-15	0.35	-9.82	0.17	-13	0.32	0.69
Cash Interest Paid	8.23	20	14	15	15	15	15	10	21	14
Cash Income Taxes Paid	20	5.02	0.09	9.42	0.02	-1.79	5.00	5.56	2.08	-0.26

This table presents Olaplex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Total Assets	1,698	1,740	1,768
Total Current Assets	522	613	690
Cash & Equivalents	323	466	586
Accounts Receivable	46	41	15
Inventories, net	144	96	75
Prepaid Expenses	-	9.95	14
Plant, Property, & Equipment, net	1.03	0.93	1.44
Total Noncurrent Assets	1,174	1,126	1,077
Goodwill	168	168	168
Intangible Assets	995	948	900
Other Noncurrent Operating Assets	11	10	8.72
Total Liabilities & Shareholders' Equity	1,698	1,740	1,768
Total Liabilities	917	895	893
Total Current Liabilities	55	56	65
Short-Term Debt	8.44	6.75	6.75
Accounts Payable	9.75	7.07	10
Accrued Expenses	17	30	36
Other Current Liabilities	16	-	12
Total Noncurrent Liabilities	862	839	829
Long-Term Debt	654	649	644
Noncurrent Deferred & Payable Income Tax Liabilities	1.62	3.02	5.16
Other Noncurrent Operating Liabilities	206	187	180
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	781	845	874
Total Preferred & Common Equity	781	845	874
Preferred Stock	0.00	0.00	0.00
Total Common Equity	781	845	874
Common Stock	314	317	329
Retained Earnings	465	526	546
Accumulated Other Comprehensive Income / (Loss)	2.58	1.37	-0.77

This table presents Olaplex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,697	1,726	1,723	1,742	1,753	1,757	1,759
Total Current Assets	497	564	571	601	639	654	670
Cash & Equivalents	249	369	378	430	508	508	539
Accounts Receivable	93	46	50	52	26	34	35
Inventories, net	151	132	129	113	95	100	86
Other Current Assets	3.28	17	13	6.42	12	12	10
Plant, Property, & Equipment, net	0.61	1.03	0.93	0.93	1.24	1.23	1.24
Total Noncurrent Assets	1,199	1,161	1,151	1,141	1,113	1,101	1,088
Goodwill	168	168	168	168	168	168	168
Intangible Assets	1,007	983	972	960	936	923	911
Other Noncurrent Operating Assets	10	10	11	12	8.42	9.37	8.43
Total Liabilities & Shareholders' Equity	1,697	1,726	1,723	1,742	1,753	1,757	1,759
Total Liabilities	953	919	905	902	898	893	879
Total Current Liabilities	89	58	61	56	60	71	57
Short-Term Debt	6.75	6.75	6.75	6.75	6.75	6.75	6.75
Accounts Payable	40	26	14	13	17	23	11
Accrued Expenses	26	20	25	17	18	23	20
Current Deferred & Payable Income Tax Liabilities	16	5.80	16	2.50	4.92	5.34	5.65
Other Current Liabilities	-	-	-	16	13	13	13
Total Noncurrent Liabilities	864	861	844	846	838	823	823
Long-Term Debt	656	653	652	650	648	646	645
Noncurrent Deferred & Payable Income Tax Liabilities	-	2.30	2.75	4.07	2.68	2.14	3.64
Other Noncurrent Operating Liabilities	-	-	189	191	188	174	174
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	744	807	818	840	856	863	880
Total Preferred & Common Equity	744	807	818	840	856	863	880
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	744	807	818	840	856	863	880
Common Stock	311	319	322	325	321	323	326
Retained Earnings	431	486	492	512	534	540	555
Accumulated Other Comprehensive Income / (Loss)	1.93	2.02	3.67	2.81	1.00	-0.08	-0.99

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	2022	2023	2024
Growth Metrics	-	-	-
Revenue Growth	17.70%	-34.93%	-7.77%
EBITDA Growth	7.05%	-59.62%	-30.68%
EBIT Growth	8.45%	-68.28%	-47.24%
NOPAT Growth	8.85%	-70.18%	-44.11%
Net Income Growth	10.55%	-74.77%	-68.30%
EPS Growth	9.38%	-74.29%	-66.67%
Operating Cash Flow Growth	27.64%	-30.47%	-19.41%
Free Cash Flow Firm Growth	103.48%	-64.72%	-16.98%
Invested Capital Growth	-15.16%	-7.72%	-9.23%
Revenue Q/Q Growth	-4.83%	-3.98%	-2.53%
EBITDA Q/Q Growth	-10.89%	-12.53%	-19.24%
EBIT Q/Q Growth	-11.98%	-18.11%	-31.69%
NOPAT Q/Q Growth	-12.23%	-21.93%	-22.40%
Net Income Q/Q Growth	-12.75%	-24.08%	-53.98%
EPS Q/Q Growth	-12.50%	-18.18%	-50.00%
Operating Cash Flow Q/Q Growth	1.52%	-12.12%	0.44%
Free Cash Flow Firm Q/Q Growth	0.00%	-57.59%	4.51%
Invested Capital Q/Q Growth	-17.92%	-3.14%	-5.42%
Profitability Metrics	-	-	-
Gross Margin	73.77%	69.52%	69.15%
EBITDA Margin	59.06%	36.65%	27.55%
Operating Margin	51.74%	23.61%	15.84%
EBIT Margin	51.86%	25.28%	14.46%
Profit (Net Income) Margin	34.66%	13.44%	4.62%
Tax Burden Percent	79.96%	80.28%	72.54%
Interest Burden Percent	83.58%	66.23%	44.03%
Effective Tax Rate	20.04%	19.73%	27.46%
Return on Invested Capital (ROIC)	23.86%	8.06%	4.92%
ROIC Less NNEP Spread (ROIC-NNEP)	15.54%	-1.49%	-17.95%
Return on Net Nonoperating Assets (RNNOA)	13.54%	-0.49%	-2.65%
Return on Equity (ROE)	37.40%	7.58%	2.27%
Cash Return on Invested Capital (CROIC)	40.27%	16.10%	14.60%
Operating Return on Assets (OROA)	22.42%	6.74%	3.48%
Return on Assets (ROA)	14.98%	3.58%	1.11%
Return on Common Equity (ROCE)	37.40%	7.58%	2.27%
Return on Equity Simple (ROE_SIMPLE)	31.25%	7.29%	2.23%
Net Operating Profit after Tax (NOPAT)	291	87	49
NOPAT Margin	41.37%	18.96%	11.49%
Net Nonoperating Expense Percent (NNEP)	8.32%	9.55%	22.87%
Return On Investment Capital (ROIC_SIMPLE)	20.18%	5.79%	3.18%
Cost of Revenue to Revenue	26.23%	30.48%	30.85%
SG&A Expenses to Revenue	16.17%	36.86%	42.99%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.03%	45.91%	53.32%
Earnings before Interest and Taxes (EBIT)	365	116	61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	416	168	116
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	4.33	1.97	1.31
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.80	3.63	2.71
Price to Earnings (P/E)	13.86	27.00	58.75
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	7.22%	3.70%	1.70%
Enterprise Value to Invested Capital (EV/IC)	3.32	1.79	1.29
Enterprise Value to Revenue (EV/Rev)	5.29	4.04	2.87
Enterprise Value to EBITDA (EV/EBITDA)	8.95	11.03	10.40
Enterprise Value to EBIT (EV/EBIT)	10.19	15.99	19.82
Enterprise Value to NOPAT (EV/NOPAT)	12.77	21.32	24.95
Enterprise Value to Operating Cash Flow (EV/OCF)	14.58	10.43	8.47
Enterprise Value to Free Cash Flow (EV/FCFF)	7.57	10.68	8.41
Leverage & Solvency	-	-	-
Debt to Equity	0.85	0.78	0.74
Long-Term Debt to Equity	0.84	0.77	0.74
Financial Leverage	0.87	0.33	0.15
Leverage Ratio	2.50	2.11	2.04
Compound Leverage Factor	2.09	1.40	0.90
Debt to Total Capital	45.91%	43.70%	42.66%
Short-Term Debt to Total Capital	0.58%	0.45%	0.44%
Long-Term Debt to Total Capital	45.32%	43.25%	42.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	54.09%	56.30%	57.34%
Debt to EBITDA	1.59	3.90	5.59
Net Debt to EBITDA	0.82	1.13	0.55
Long-Term Debt to EBITDA	1.57	3.86	5.53
Debt to NOPAT	2.27	7.55	13.40
Net Debt to NOPAT	1.17	2.18	1.33
Long-Term Debt to NOPAT	2.25	7.47	13.26
Altman Z-Score	4.05	2.41	1.98
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	9.48	10.92	10.67
Quick Ratio	6.70	9.04	9.29
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	492	173	144
Operating Cash Flow to CapEx	39,280.62%	47,341.87%	12,728.47%
Free Cash Flow to Firm to Interest Expense	7.83	2.99	2.42
Operating Cash Flow to Interest Expense	4.07	3.06	2.40
Operating Cash Flow Less CapEx to Interest Expense	4.06	3.06	2.38
Efficiency Ratios	-	-	-
Asset Turnover	0.43	0.27	0.24
Accounts Receivable Turnover	16.19	10.52	15.13
Inventory Turnover	1.52	1.16	1.52
Fixed Asset Turnover	790.87	466.70	356.38
Accounts Payable Turnover	11.17	16.61	14.90
Days Sales Outstanding (DSO)	22.54	34.70	24.12
Days Inventory Outstanding (DIO)	239.90	314.05	239.48
Days Payable Outstanding (DPO)	32.67	21.98	24.49
Cash Conversion Cycle (CCC)	229.77	326.78	239.11
Capital & Investment Metrics	-	-	-
Invested Capital	1,121	1,034	939
Invested Capital Turnover	0.58	0.43	0.43
Increase / (Decrease) in Invested Capital	-200	-87	-95
Enterprise Value (EV)	3,722	1,852	1,211
Market Capitalization	3,382	1,663	1,147
Book Value per Share	$1.20	$1.29	$1.32
Tangible Book Value per Share	($0.59)	($0.41)	($0.29)
Total Capital	1,444	1,501	1,525
Total Debt	663	656	650
Total Long-Term Debt	654	649	644
Net Debt	340	189	64
Capital Expenditures (CapEx)	0.65	0.38	1.12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	153	97	46
Debt-free Net Working Capital (DFNWC)	476	564	632
Net Working Capital (NWC)	467	557	625
Net Nonoperating Expense (NNE)	47	25	29
Net Nonoperating Obligations (NNO)	340	189	64
Total Depreciation and Amortization (D&A)	51	52	55
Debt-free, Cash-free Net Working Capital to Revenue	21.69%	21.25%	10.85%
Debt-free Net Working Capital to Revenue	67.53%	123.02%	149.48%
Net Working Capital to Revenue	66.33%	121.55%	147.88%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.38	$0.09	$0.03
Adjusted Weighted Average Basic Shares Outstanding	649.09M	654.59M	661.98M
Adjusted Diluted Earnings per Share	$0.35	$0.09	$0.03
Adjusted Weighted Average Diluted Shares Outstanding	691.01M	677.58M	665.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	651.90M	660.76M	664.62M
Normalized Net Operating Profit after Tax (NOPAT)	291	87	49
Normalized NOPAT Margin	41.37%	18.96%	11.49%
Pre Tax Income Margin	43.34%	16.74%	6.37%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	5.82	2.00	1.03
NOPAT to Interest Expense	4.64	1.50	0.81
EBIT Less CapEx to Interest Expense	5.81	1.99	1.01
NOPAT Less CapEx to Interest Expense	4.63	1.49	0.80
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Olaplex's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.18%	-21.49%	-38.89%	-48.20%	-29.98%	-14.54%	-13.08%	-4.85%	-3.62%	-9.82%
EBITDA Growth	0.83%	-44.56%	-59.80%	-76.48%	-50.85%	-38.04%	-32.39%	-4.43%	-13.65%	-70.75%
EBIT Growth	-0.45%	-49.00%	-66.92%	-84.71%	-58.62%	-49.52%	-47.86%	-11.81%	-19.85%	-108.55%
NOPAT Growth	3.50%	-51.39%	-65.80%	-84.81%	-59.85%	-63.46%	-50.34%	-15.63%	-26.06%	-84.81%
Net Income Growth	7.37%	-51.48%	-66.17%	-92.98%	-66.48%	-58.07%	-63.05%	-6.12%	-27.34%	-162.41%
EPS Growth	12.50%	-55.56%	-66.67%	-92.31%	-66.67%	-50.00%	-66.67%	0.00%	-33.33%	-150.00%
Operating Cash Flow Growth	-2.92%	5.47%	-33.18%	-51.86%	-0.64%	-33.30%	-9.11%	-39.84%	-37.35%	1.27%
Free Cash Flow Firm Growth	102.22%	0.00%	105.01%	121.47%	1,074.33%	-57.85%	402.26%	-62.38%	-70.48%	-3.02%
Invested Capital Growth	3.27%	-15.16%	-2.48%	-18.88%	-21.80%	-7.72%	-23.03%	-8.14%	-7.04%	-9.23%
Revenue Q/Q Growth	-16.33%	-25.92%	-12.95%	-4.00%	13.10%	-9.58%	-11.47%	5.09%	14.56%	-15.40%
EBITDA Q/Q Growth	-23.92%	-36.94%	-23.42%	-35.97%	58.97%	-20.51%	-16.44%	-9.49%	43.64%	-73.07%
EBIT Q/Q Growth	-27.24%	-40.15%	-30.79%	-49.28%	96.97%	-26.99%	-28.51%	-14.23%	79.01%	-107.79%
NOPAT Q/Q Growth	-25.78%	-45.88%	-23.15%	-50.80%	96.24%	-50.76%	4.44%	-16.41%	71.99%	-89.88%
Net Income Q/Q Growth	-30.73%	-44.65%	-37.67%	-70.64%	230.83%	-30.76%	-45.07%	-25.39%	156.05%	-159.47%
EPS Q/Q Growth	-30.77%	-55.56%	-25.00%	-66.67%	200.00%	-33.33%	-50.00%	0.00%	100.00%	-150.00%
Operating Cash Flow Q/Q Growth	-4.15%	36.77%	-34.59%	-43.86%	97.83%	-8.19%	-10.87%	-62.84%	106.02%	48.41%
Free Cash Flow Firm Q/Q Growth	102.21%	759.45%	-73.75%	331.00%	20.78%	-69.15%	212.80%	-67.72%	-5.23%	1.34%
Invested Capital Q/Q Growth	0.90%	-17.92%	16.22%	-15.72%	-2.73%	-3.14%	-3.06%	0.58%	-1.57%	-5.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	73.58%	70.45%	71.02%	70.94%	67.62%	68.73%	72.13%	69.69%	68.64%	66.28%
EBITDA Margin	56.85%	48.39%	42.57%	28.39%	39.90%	35.08%	33.11%	28.52%	35.75%	11.38%
Operating Margin	50.26%	36.00%	31.25%	17.17%	29.73%	15.36%	19.83%	15.66%	23.51%	3.02%
EBIT Margin	48.99%	39.58%	31.47%	16.62%	28.95%	23.38%	18.88%	15.41%	24.07%	-2.22%
Profit (Net Income) Margin	34.44%	25.73%	18.42%	5.64%	16.48%	12.62%	7.83%	5.56%	12.43%	-8.74%
Tax Burden Percent	80.01%	81.62%	82.99%	77.40%	77.56%	81.75%	74.70%	75.26%	75.26%	81.50%
Interest Burden Percent	87.85%	79.66%	70.55%	43.80%	73.41%	66.05%	55.54%	47.95%	68.59%	483.74%
Effective Tax Rate	19.99%	18.38%	17.01%	22.60%	22.44%	18.25%	25.30%	24.74%	24.74%	0.00%
Return on Invested Capital (ROIC)	22.14%	16.94%	12.42%	5.75%	9.05%	5.34%	5.70%	4.90%	7.45%	0.91%
ROIC Less NNEP Spread (ROIC-NNEP)	20.78%	16.11%	11.05%	4.00%	7.13%	5.37%	3.55%	1.86%	3.76%	-7.71%
Return on Net Nonoperating Assets (RNNOA)	25.88%	14.03%	9.84%	2.55%	3.82%	1.75%	1.37%	0.47%	0.74%	-1.14%
Return on Equity (ROE)	48.02%	30.97%	22.26%	8.30%	12.87%	7.09%	7.07%	5.37%	8.19%	-0.23%
Cash Return on Invested Capital (CROIC)	0.00%	40.27%	20.27%	33.38%	33.61%	16.10%	32.29%	15.13%	13.37%	14.60%
Operating Return on Assets (OROA)	22.73%	17.11%	12.12%	5.25%	8.04%	6.23%	4.81%	3.88%	5.96%	-0.53%
Return on Assets (ROA)	15.98%	11.12%	7.10%	1.78%	4.58%	3.37%	2.00%	1.40%	3.08%	-2.10%
Return on Common Equity (ROCE)	48.02%	30.97%	22.26%	8.30%	12.87%	7.09%	7.07%	5.37%	8.19%	-0.23%
Return on Equity Simple (ROE_SIMPLE)	37.60%	0.00%	25.18%	14.86%	9.65%	0.00%	5.65%	5.56%	4.82%	0.00%
Net Operating Profit after Tax (NOPAT)	71	38	30	15	28	14	15	12	21	2.13
NOPAT Margin	40.22%	29.38%	25.94%	13.29%	23.06%	12.56%	14.82%	11.79%	17.69%	2.12%
Net Nonoperating Expense Percent (NNEP)	1.37%	0.84%	1.38%	1.75%	1.91%	-0.03%	2.15%	3.04%	3.68%	8.61%
Return On Investment Capital (ROIC_SIMPLE)	-	2.66%	-	-	-	0.94%	-	-	-	0.14%
Cost of Revenue to Revenue	26.42%	29.55%	28.98%	29.06%	32.38%	31.27%	27.87%	30.31%	31.36%	33.72%
SG&A Expenses to Revenue	17.46%	26.50%	30.69%	44.32%	29.49%	44.01%	40.88%	43.70%	36.07%	52.48%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.31%	34.45%	39.76%	53.77%	37.89%	53.36%	52.30%	54.03%	45.13%	63.26%
Earnings before Interest and Taxes (EBIT)	86	52	36	18	36	26	19	16	29	-2.23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	100	63	48	31	49	39	33	30	43	11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.33	4.33	3.45	2.98	1.52	1.97	1.48	1.18	1.77	1.31
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	8.38	4.80	4.41	4.59	2.67	3.63	2.86	2.33	3.59	2.71
Price to Earnings (P/E)	22.16	13.86	13.71	20.03	15.74	27.00	26.23	21.24	36.67	58.75
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.51%	7.22%	7.30%	4.99%	6.35%	3.70%	3.81%	4.71%	2.73%	1.70%
Enterprise Value to Invested Capital (EV/IC)	4.84	3.32	2.36	2.47	1.41	1.79	1.41	1.15	1.68	1.29
Enterprise Value to Revenue (EV/Rev)	8.93	5.29	4.87	5.12	3.15	4.04	3.19	2.66	3.85	2.87
Enterprise Value to EBITDA (EV/EBITDA)	14.17	8.95	8.94	11.17	7.83	11.03	9.30	7.72	11.58	10.40
Enterprise Value to EBIT (EV/EBIT)	15.94	10.19	10.50	14.12	10.63	15.99	14.34	12.06	18.65	19.82
Enterprise Value to NOPAT (EV/NOPAT)	19.92	12.77	13.12	17.67	13.52	21.32	19.61	16.63	26.67	24.95
Enterprise Value to Operating Cash Flow (EV/OCF)	26.29	14.58	13.28	13.41	7.45	10.43	8.18	7.17	11.71	8.47
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	7.57	11.49	6.63	3.68	10.68	3.80	7.31	12.11	8.41
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.89	0.85	0.82	0.81	0.78	0.78	0.76	0.76	0.74	0.74
Long-Term Debt to Equity	0.88	0.84	0.81	0.80	0.77	0.77	0.76	0.75	0.73	0.74
Financial Leverage	1.25	0.87	0.89	0.64	0.54	0.33	0.39	0.25	0.20	0.15
Leverage Ratio	2.67	2.50	2.35	2.24	2.17	2.11	2.09	2.07	2.04	2.04
Compound Leverage Factor	2.34	1.99	1.66	0.98	1.59	1.40	1.16	0.99	1.40	9.87
Debt to Total Capital	47.10%	45.91%	44.99%	44.60%	43.88%	43.70%	43.34%	43.07%	42.56%	42.66%
Short-Term Debt to Total Capital	0.48%	0.58%	0.46%	0.46%	0.45%	0.45%	0.45%	0.45%	0.44%	0.44%
Long-Term Debt to Total Capital	46.62%	45.32%	44.53%	44.14%	43.43%	43.25%	42.89%	42.62%	42.12%	42.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	52.90%	54.09%	55.01%	55.40%	56.12%	56.30%	56.66%	56.93%	57.44%	57.34%
Debt to EBITDA	1.42	1.59	1.92	2.71	3.42	3.90	4.30	4.33	4.52	5.59
Net Debt to EBITDA	0.88	0.82	0.84	1.15	1.18	1.13	0.97	0.96	0.78	0.55
Long-Term Debt to EBITDA	1.40	1.57	1.90	2.68	3.39	3.86	4.25	4.28	4.47	5.53
Debt to NOPAT	2.00	2.27	2.82	4.29	5.91	7.55	9.07	9.33	10.42	13.40
Net Debt to NOPAT	1.24	1.17	1.24	1.82	2.04	2.18	2.04	2.07	1.81	1.33
Long-Term Debt to NOPAT	1.98	2.25	2.79	4.24	5.84	7.47	8.97	9.23	10.31	13.26
Altman Z-Score	5.15	3.44	3.00	2.71	1.98	2.23	1.96	1.79	2.22	1.86
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.61	9.48	9.68	9.32	10.69	10.92	10.71	9.27	11.84	10.67
Quick Ratio	3.87	6.70	7.12	7.00	8.57	9.04	8.93	7.67	10.14	9.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	28	239	63	270	326	101	315	102	96	98
Operating Cash Flow to CapEx	215,016.00%	13,366.73%	44,942.99%	128,561.90%	48,117.12%	36,055.15%	9,691.13%	15,038.89%	25,542.75%	11,441.94%
Free Cash Flow to Firm to Interest Expense	2.65	17.95	4.50	18.40	22.20	6.86	21.70	6.96	6.17	6.56
Operating Cash Flow to Interest Expense	5.12	5.53	3.46	1.84	3.64	3.34	3.01	1.11	2.14	3.34
Operating Cash Flow Less CapEx to Interest Expense	5.12	5.49	3.45	1.84	3.63	3.33	2.98	1.11	2.14	3.31
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.43	0.39	0.32	0.28	0.27	0.25	0.25	0.25	0.24
Accounts Receivable Turnover	9.70	16.19	11.04	8.06	6.58	10.52	12.43	10.40	10.00	15.13
Inventory Turnover	1.64	1.52	1.38	1.12	1.09	1.16	1.18	1.17	1.32	1.52
Fixed Asset Turnover	1,042.33	790.87	715.59	661.93	618.67	466.70	391.19	406.23	400.23	356.38
Accounts Payable Turnover	6.68	11.17	5.86	5.44	5.41	16.61	6.25	7.31	10.63	14.90
Days Sales Outstanding (DSO)	37.62	22.54	33.05	45.31	55.50	34.70	29.35	35.10	36.51	24.12
Days Inventory Outstanding (DIO)	222.97	239.90	263.63	327.12	336.13	314.05	308.11	311.39	276.03	239.48
Days Payable Outstanding (DPO)	54.62	32.67	62.26	67.11	67.51	21.98	58.43	49.96	34.32	24.49
Cash Conversion Cycle (CCC)	205.97	229.77	234.42	305.32	324.13	326.78	279.04	296.54	278.22	239.11
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,366	1,121	1,303	1,098	1,068	1,034	1,003	1,009	993	939
Invested Capital Turnover	0.55	0.58	0.48	0.43	0.39	0.43	0.38	0.42	0.42	0.43
Increase / (Decrease) in Invested Capital	43	-200	-33	-256	-298	-87	-300	-89	-75	-95
Enterprise Value (EV)	6,612	3,722	3,074	2,714	1,504	1,852	1,416	1,164	1,669	1,211
Market Capitalization	6,199	3,382	2,784	2,434	1,277	1,663	1,269	1,019	1,556	1,147
Book Value per Share	$1.15	$1.20	$1.24	$1.25	$1.28	$1.29	$1.30	$1.30	$1.33	$1.32
Tangible Book Value per Share	($0.66)	($0.59)	($0.53)	($0.49)	($0.44)	($0.41)	($0.38)	($0.35)	($0.30)	($0.29)
Total Capital	1,406	1,444	1,466	1,476	1,497	1,501	1,510	1,516	1,532	1,525
Total Debt	662	663	660	658	657	656	654	653	652	650
Total Long-Term Debt	656	654	653	652	650	649	648	646	645	644
Net Debt	413	340	290	280	228	189	147	145	113	64
Capital Expenditures (CapEx)	0.03	0.55	0.11	0.02	0.11	0.14	0.45	0.11	0.13	0.43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	166	153	143	138	122	97	79	83	81	46
Debt-free Net Working Capital (DFNWC)	415	476	512	516	551	564	587	591	620	632
Net Working Capital (NWC)	409	467	505	509	544	557	580	584	613	625
Net Nonoperating Expense (NNE)	10	4.77	8.55	8.36	8.13	-0.07	6.91	6.47	6.27	11
Net Nonoperating Obligations (NNO)	622	340	496	280	228	189	147	145	113	64
Total Depreciation and Amortization (D&A)	14	12	13	13	14	13	14	14	14	14
Debt-free, Cash-free Net Working Capital to Revenue	22.44%	21.69%	22.59%	25.97%	25.48%	21.25%	17.82%	18.87%	18.70%	10.85%
Debt-free Net Working Capital to Revenue	56.14%	67.53%	81.04%	97.34%	115.48%	123.02%	132.27%	134.80%	142.95%	149.48%
Net Working Capital to Revenue	55.22%	66.33%	79.97%	96.07%	114.07%	121.55%	130.75%	133.26%	141.39%	147.88%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.09	$0.05	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)
Adjusted Weighted Average Basic Shares Outstanding	649.10M	649.09M	651.73M	654.35M	654.70M	654.59M	660.82M	661.73M	662.25M	661.98M
Adjusted Diluted Earnings per Share	$0.09	$0.04	$0.03	$0.01	$0.03	$0.02	$0.01	$0.01	$0.02	($0.01)
Adjusted Weighted Average Diluted Shares Outstanding	691.26M	691.01M	683.49M	680.35M	678.76M	677.58M	663.57M	663.55M	666.15M	665.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	649.18M	651.90M	654.28M	654.70M	654.73M	660.76M	661.76M	661.98M	662.92M	664.62M
Normalized Net Operating Profit after Tax (NOPAT)	71	38	30	15	28	14	15	12	21	2.13
Normalized NOPAT Margin	40.22%	29.38%	25.94%	13.29%	23.06%	12.56%	14.82%	11.79%	17.69%	2.12%
Pre Tax Income Margin	43.04%	31.52%	22.20%	7.28%	21.25%	15.44%	10.48%	7.39%	16.51%	-10.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.23	3.89	2.57	1.24	2.43	1.78	1.29	1.10	1.84	-0.15
NOPAT to Interest Expense	6.76	2.89	2.12	0.99	1.94	0.96	1.01	0.84	1.35	0.14
EBIT Less CapEx to Interest Expense	8.23	3.85	2.56	1.24	2.43	1.77	1.26	1.09	1.83	-0.18
NOPAT Less CapEx to Interest Expense	6.76	2.85	2.11	0.99	1.93	0.95	0.98	0.83	1.34	0.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Olaplex's Financials

When does Olaplex's fiscal year end?

According to the most recent income statement we have on file, Olaplex's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Olaplex's net income changed over the last 2 years?

Olaplex's net income appears to be on a downward trend, with a most recent value of $19.52 million in 2024, falling from $244.07 million in 2022. The previous period was $61.59 million in 2023.

What is Olaplex's operating income?

Olaplex's total operating income in 2024 was $66.94 million, based on the following breakdown:

Total Gross Profit: $292.29 million
Total Operating Expenses: $225.35 million

How has Olaplex revenue changed over the last 2 years?

Over the last 2 years, Olaplex's total revenue changed from $704.27 million in 2022 to $422.67 million in 2024, a change of -40.0%.

How much debt does Olaplex have?

Olaplex's total liabilities were at $893.32 million at the end of 2024, a 0.2% decrease from 2023, and a 2.6% decrease since 2022.

How much cash does Olaplex have?

In the past 2 years, Olaplex's cash and equivalents has ranged from $322.81 million in 2022 to $585.97 million in 2024, and is currently $585.97 million as of their latest financial filing in 2024.

How has Olaplex's book value per share changed over the last 2 years?

Over the last 2 years, Olaplex's book value per share changed from 1.20 in 2022 to 1.32 in 2024, a change of 9.6%.

Remove Ads

Related Companies

This page (NASDAQ:OLPX) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Olaplex (OLPX) Financials

Frequently Asked Questions About Olaplex's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Olaplex (OLPX) Financials

Annual Income Statements for Olaplex

Quarterly Income Statements for Olaplex

Annual Cash Flow Statements for Olaplex

Quarterly Cash Flow Statements for Olaplex

Annual Balance Sheets for Olaplex

Quarterly Balance Sheets for Olaplex

Annual Metrics and Ratios for Olaplex

Quarterly Metrics and Ratios for Olaplex

Frequently Asked Questions About Olaplex's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools